Vice Provost and Dean of Research
Showing 2,321-2,340 of 2,497 Results
-
Jia Wang
Medical/Radiation Physicist, Environmental Health and Safety (EH&S)
BioI am the head of the Diagnostic Medical Physics group at Environmental Health and Safety department. Our group provides medical physics services for Stanford Health Care, Lucille Packard Children's Hospital, and Veterans Affairs Palo Alto Health Care System. The scope of our work includes:
• Radiation safety of X-ray imaging practice to ascertain the compliance of State and Federal regulations, The Joint Commission recommendations, requirements from related accreditation bodies and University policies
• Quality control program of X-ray imaging practice (Computed tomography, Interventional equipment, Fluoroscopy and Radiography) for Imaging and Interventional Services at hospitals
• Radiation dose monitoring and CT protocol optimization; Work with each clinical section on task-specific CT Dose and Image Quality optimization by utilizing our state-of-the-art CT equipment and novel iterative reconstruction techniques
• Review proposed research uses of x-rays in human subjects for Stanford IRB: evaluate doses and estimate risks and advise research investigators on radiation safety issues and how to solve related problems.
• Staff and trainee education on topics including CT technology, CT dose optimization, Fluoroscopy dose optimization, and radiation risk from ionizing imaging exams
• Clinical innovation: we work with physicians and hospital imaging and interventional teams on clinical research projects and activities that can be readily translated to patient care in Stanford affiliated health care systems -
Li Wang
Assistant Professor of Biology
Current Research and Scholarly InterestsWe study how the extraordinary diversity of cells and synapses in the brain is generated, organized, and maintained, and how these processes are disrupted in diseases such as neurodevelopmental disorders and brain cancer. By combining single-cell and spatial genomics, lineage tracing, perturbation screens, synaptic proteomics, and machine learning models, we aim to uncover the molecular rules that define neural identity and connectivity.
Our research spans two interrelated themes, each grounded in human biology and driven by cutting-edge technologies. By comparing these processes across species, we aim to uncover both conserved mechanisms and human-specific innovations that define the unique features of the human brain. -
Paul J. Wang, MD
John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering
Current Research and Scholarly InterestsDr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang is committed to addressing disparities in care and is actively involved in increasing diversity in clinical trials.
-
Qin Wang
Visiting Researcher Student, GR Visiting Researcher
BioQin Wang is a Visiting Student Researcher at the Stanford Center on China’s Economy and Institutions (2025–26). He is pursuing his Ph.D. at the Northeast Normal University. His research focuses on rural teachers’ professional development and rural education policy. In his recent work, he has paid particular attention to the optimization of teacher resource allocation in regions experiencing a decline in school-age populations. By integrating demographic forecasting, institutional design, and technological support, his studies aim to address the challenges of uneven teacher distribution caused by demographic shifts.
-
Shan X. Wang
Leland T. Edwards Professor in the School of Engineering and Professor of Electrical Engineering and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
On Partial Leave from 04/01/2026 To 06/30/2026Current Research and Scholarly InterestsShan Wang was named the Leland T. Edwards Professor in the School of Engineering in 2018. He directs the Center for Magnetic Nanotechnology and is a leading expert in Edge AI, biosensors, information storage and spintronics. His research and inventions span across a variety of areas including Edge AI, magnetic biochips, in vitro diagnostics, cancer biomarkers, magnetic nanoparticles, magnetic sensors, magnetoresistive random access memory, and magnetic integrated inductors.
-
Sophia Y. Wang, MD, MS
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsI use and integrate a wide variety of data sources in my research, spanning both structured and unstructured forms, including national survey datasets, health insurance claims data, patient generated online text, surgical video, and electronic health records. I investigate outcomes of treatments for glaucoma and cataract, as well as other areas of ophthalmology. My focus is on developing artificial intelligence methods to predict ophthalmology outcomes, while ensuring fairness.
-
Sui Wang, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Taia T. Wang, MD, PhD, MSCI
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsLaboratory of Mechanisms in Human Immunity and Disease Pathogenesis
-
Xinnan Wang
Professor of Neurosurgery
Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.
-
Yuyan Wang
Assistant Professor of Marketing at the Graduate School of Business
BioYuyan Wang is an assistant professor of marketing and Kevin J. O’Donohue Family Faculty Scholar for 2024–2025 at Stanford Graduate School of Business. With over six years of industry experience at Google DeepMind and Uber as a machine learning researcher, she has designed algorithms for understanding and improving the long-term values of recommender systems, many of which have been deployed globally in multiple products at Google and Uber Eats. Her background is in statistics, with a PhD from the Department of Operations Research & Financial Engineering (ORFE) at Princeton University and a BSc from the Special Class for the Gifted Young at the University of Science of Technology of China. She has received the Steven Shugan Best Junior Faculty Paper Award at the AI in Management Conference (AIM) in 2025, and the Best Paper Award at the Conference on Information Systems and Technology (CIST) in 2022.
At Stanford GSB, Wang created and taught Understanding AI Technologies for Business Problems, the school’s first technical MBA course on AI. -
Victoria Ward
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, digital health, preterm birth, human trafficking
-
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
